ALTSTATION.IO

International Business Machines Corporation (IBM) Stock Analysis

By Nova Skye | AltStation.io | Updated November 10, 2026

Price
$247.56
Change
+1.05%
Market Cap
$233.98B
Avg Volume
5.4M

Company Overview

IBM is an enterprise technology powerhouse based in Armonk, New York, operating in the Information Technology Services industry. The company generates revenue across four distinct units: Software, Consulting, Infrastructure, and Financing. They sell hybrid cloud platforms, AI software, data streaming systems, servers, and storage to large corporations and government bodies like the UK Ministry of Defence. IBM rounds out its catalog by deploying consulting teams to help enterprise clients modernize legacy applications and implement AI-powered workflows.

IBM operates as an entrenched enterprise player rather than a standalone cloud hyperscaler. Its main advantage is deep integration across complex hybrid cloud environments, backed by in-house commercial financing that funds major client deployments. Instead of competing directly against public cloud giants for standard workloads, IBM partners with them, integrating systems alongside Amazon Web Services, Microsoft, Oracle, SAP, Adobe, and Salesforce. The core challenge is maintaining high software and consulting relevance while operating within the ecosystems of these same massive tech partners.

The company is executing a clear strategic pivot toward enterprise AI and hybrid cloud infrastructure, moving far beyond its 1911 corporate roots. Recent strategic moves highlight this direction, including a collaboration with Arm Holdings to develop dual-architecture hardware for AI workloads and a partnership with three.ws to advance AI-powered 3D agent technology. IBM is also reinforcing open source software supply chains with Lightwell and running operational logistics for defense clients through Team ORION. IBM is actively betting its future on being the essential AI, software, and integration layer across enterprise IT.

Key Financials
Market Cap
$233.98B
Revenue
$69.87B
EBITDA
$16.63B
Gross Margin
58.0%
Profit Margin
16.0%
Revenue Growth
4.7%
Total Cash
$11.06B
Total Debt
$67.14B
Free Cash Flow
$12.35B


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
21.12
Forward P/E
18.71
Beta
0.76
52-Week High
$332.46
52-Week Low
$199.19
EPS
$11.72
50-Day Avg
$236.75
200-Day Avg
$247.97
Price/Book
6.58
IBM 52-Week Stock Chart
Technical Analysis
IBM trades at $247.56, placing it 37% of the way from its $197.77 52-week low to its $330.09 high. The stock is -25.44% off that high and 24.44% above the low. The 20-day moving average is $246.42, with the technical data placing the price at -0.13% versus that average. Momentum is mixed: IBM lost 2.53% over the last five trading days but gained 8.41% over the last 20. Near-term support sits at $219.93, while $258.28 is the resistance level to beat.


Recent News and Developments

IBM and Microsoft launch enterprise AI agent platform

IBM and Microsoft launched Imagine Enterprise on November 10 with more than 6,000 prebuilt AI agents and assets. The platform initially targets financial services, insurance, and retail, with IBM Consulting providing deployment support. Source: IBM Newsroom

Apptio adds tools for tracking AI spending and returns

IBM’s Apptio introduced new connections for tracking AI usage, token costs, budgets, and business returns on November 9. IBM said 85% of surveyed technology executives lacked full visibility into real-time AI spending, giving this product update a clear customer problem to solve. Source: IBM Newsroom

Evercore keeps IBM at Outperform with $275 target

Evercore ISI reiterated its Outperform rating and $275 price target on November 6. The firm noted IBM had gained 12% since September 30 while the S&P 500 fell 4%, and its sum-of-the-parts analysis produced an implied value of $290 per share. Source: Investing.com



Market Sentiment and Analyst Recommendations

Bull Case
IBM is producing $69.87 billion in revenue with 4.7% revenue growth, giving the company scale and positive momentum. Its $247.56 share price is below the $259.30 consensus analyst target, and 23 analysts collectively rate the stock a buy. Evercore is more bullish, maintaining a $275 target and calculating an implied value of $290 per share. The Microsoft partnership adds a credible enterprise AI catalyst through Imagine Enterprise, which launched November 10 with more than 6,000 prebuilt AI agents and assets. Apptio is also attacking a measurable problem: 85% of surveyed technology executives lacked full visibility into real-time AI spending. IBM’s operational Quantum System Two adds another differentiated technology asset, while the stock’s 8.41% gain over 20 trading days shows buyers are responding.
Bear Case
IBM’s balance sheet is the clearest concern, with $67.14 billion in total debt against $11.06 billion in cash. The stock also trades at 21.12 times earnings despite revenue growth of only 4.7%, leaving limited room for weak execution. The $259.30 consensus target is above the $247.56 share price, but the analyst range stretches down to $174.00. Technical momentum has weakened over the last five trading days, with shares falling 2.53%. The stock remains -25.44% off its 52-week high, showing that the longer-term chart has not repaired the decline. New AI and quantum products are promising, but IBM still has to convert those announcements into revenue growth strong enough to justify the valuation and debt load.
What to Watch
The first test is whether IBM can break through the $258.28 30-day resistance level. A move above that level would also put the stock closer to the $259.30 consensus analyst target. On the downside, $219.93 is the near-term support level; losing it would weaken the technical setup. Investors should track adoption of Imagine Enterprise after its November 10 launch, particularly whether its more than 6,000 AI agents and assets translate into deployment work for IBM Consulting. Apptio’s November 9 product update also matters because it targets AI usage, token costs, budgets, and returns, an area where 85% of surveyed technology executives reported incomplete visibility. The fundamental thesis improves if revenue growth rises above 4.7%, while weaker growth would make the 21.12 P/E and $67.14 billion debt load harder to defend.
Analyst Consensus
BUY

Based on 23 analyst opinions
Low Target
$174.00
Mean Target
$259.30
High Target
$300.00


Earnings and Financial Data

Sector
Technology
Industry
Information Technology Services
Employees
264,300
Earnings & Dividends
Next Earnings
Jan 27, 2027
EPS (Trailing)
$11.72
Dividend Yield
276.0%
Payout Ratio
57.5%

Frequently Asked Questions

Is IBM a good stock to buy?
IBM has a buy recommendation from 23 analysts, 4.7% revenue growth, and a $259.30 consensus target versus a $247.56 share price. The takeaway is that analysts are positive, but the upside depends on IBM sustaining growth.
What is IBM’s price target?
The consensus analyst target is $259.30, with estimates ranging from $174.00 to $300.00. The takeaway is that the average target sits above the current $247.56 price, but analyst expectations vary widely.
Is IBM stock overvalued?
IBM trades at a P/E ratio of 21.12 while revenue is growing 4.7%. The takeaway is that the valuation requires continued growth and does not leave much room for execution problems.
What are IBM’s support and resistance levels?
Near-term support is $219.93, based on the 30-day low, while resistance is $258.28, based on the 30-day high. The takeaway is that these are the key levels defining IBM’s current trading range.
How far is IBM stock from its 52-week high?
IBM is -25.44% off its $330.09 52-week high and 24.44% above its $197.77 52-week low. The takeaway is that the stock has recovered from the low but remains well below its peak.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated November 10, 2026.